IP Library Granted Patent US 7,687,614
Granted Patent B2
US 7,687,614 · App. 10/931,304 · Granted Mar 30, 2010

Monomeric and dimeric fluorescent protein variants and methods for making same

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,687,614
App. No.
10/931,304
Granted
Mar 30, 2010
Kind
B2
Abstract

The present invention relates generally to fluorescent proteins and fluorescent protein variants, and more specifically to monomeric and dimeric forms of Anthozoan fluorescent proteins. In one aspect, the present invention provides variants of fluorescent proteins, where the variants have a reduced propensity to tetramerize, and form dimeric or monomeric structures. In a further aspect, the present invention provides variants of fluorescent proteins, the variants being characterized by more efficient maturation than corresponding fluorescent proteins from which they are derived. The invention also relates to methods of making and using such fluorescent proteins and fluorescent protein variants, including fluorescent protein monomers and dimers.

Claims (9)

1. An isolated polynucleotide sequence encoding a fluorescent variant of a wild type Discoma red fluorescent protein (DsRed) having a reduced propensity to form tetramers, the polynucleotide encoding a protein comprising one or more amino acid substitutions selected from the group consisting of V7I, S62T, Q66T, T147S, M182K, K194I, T195V, D196G, and Q213L numbered in accordance with SEQ ID NO:8; wherein the encoded protein has at least 89% sequence identity with SEQ ID NO:98.

2. A vector comprising the isolated polynucleotide of claim 1 .

3. A host cell comprising the vector of claim 2 .

4. A kit comprising the polynucleotide sequence of claim 1 .

5. The isolated polynucleotide of claim 1 , wherein the protein further comprises the amino acid residue substitution N8D numbered in accordance with SEQ ID NO:114 in addition to amino acid substitutions: M163Q and R17H numbered in accordance with SEQ ID NO:8.

6. The isolated polynucleotide of claim 1 , wherein the protein further comprises the amino acid residue substitution N8D numbered in accordance with SEQ ID NO:114 in addition to amino acid substitutions: M163Q, T195V, K194N and D196N numbered in accordance with SEQ ID NO:8.

7. The isolated polynucleotide of claim 1 , wherein the protein further comprises the following amino acid residue substitutions: T195V, Q213L, S62T and Q64N numbered in accordance with SEQ ID NO:8.

8. The isolated polynucleotide of claim 1 , wherein the protein further comprises the following amino acid residue alterations substitutions: T195V, T41F and L83F numbered in accordance with SEQ ID NO:8.

9. The isolated polynucleotide of claim 1 , wherein the protein comprises SEQ ID NO:98.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 18, 2011
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026768/0856 →
CONFIRMATORY LICENSE Recorded Jul 18, 2008
From: UNIVERSITY OF CALIFORNIA, SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021264/0482 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2005
From: TSIEN, ROGER Y.; CAMPBELL, ROBERT E.; SHANER, NATHAN C.
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA THE
Reel/Frame 016585/0093 →
Continuity (5)
Continuation In Part 1020920800 · Jul 29, 2002
Continuation In Part 1012125800 · Apr 10, 2002
Continuation In Part 0986653800 · May 24, 2001
Continuation In Part 0979430800 · Feb 26, 2001
Related Publication 20050196768A1 · Sep 8, 2005